Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSL | Sydney | Salute | Prodotti farmaceutici | 137,20 Mrd A$ | 33,2x | 1,66 | 283,14 A$ | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18,3% Rialzo | Fai l’upgrade a Pro+ | |
Resmed DRC | Sydney | Salute | Attrezzature e forniture medicali | 56,35 Mrd A$ | 32,8x | 1,45 | 38,10 A$ | 0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 9,9% Rialzo | Fai l’upgrade a Pro+ | |
Pro Medicus Ltd | Sydney | Salute | Attrezzature e forniture medicali | 27,38 Mrd A$ | 332,3x | 8,74 | 261,24 A$ | 1,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -40,5% Ribasso | Fai l’upgrade a Pro+ | |
Fisher & Paykel Healthcare Corp | Sydney | Salute | Attrezzature e forniture medicali | 20,19 Mrd A$ | 123,5x | -3,84 | 34,26 A$ | -1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 0,2% Rialzo | Fai l’upgrade a Pro+ | |
Cochlear | Sydney | Salute | Attrezzature e forniture medicali | 19,97 Mrd A$ | 56x | 2,93 | 303,16 A$ | -0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -1,8% Ribasso | Fai l’upgrade a Pro+ | |
Sonic Health | Sydney | Salute | Fornitori e servizi sanitari | 13,95 Mrd A$ | 27,1x | -1,03 | 28,87 A$ | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -4,7% Ribasso | Fai l’upgrade a Pro+ | |
Ramsay Health | Sydney | Salute | Fornitori e servizi sanitari | 9,33 Mrd A$ | 10,6x | 0,17 | 40,50 A$ | -0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 3,8% Rialzo | Fai l’upgrade a Pro+ | |
Ramsay Health Care Pref | Sydney | Salute | Fornitori e servizi sanitari | 9,33 Mrd A$ | 10,6x | 105,35 A$ | -0,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Telix Pharma | Sydney | Salute | Ricerca medica e biotecnologica | 8,45 Mrd A$ | 164,8x | 0,85 | 25,10 A$ | 1,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 1,6% Rialzo | Fai l’upgrade a Pro+ | |
Ebos | Sydney | Salute | Prodotti farmaceutici | 6,71 Mrd A$ | 24,5x | 3,92 | 34,48 A$ | -1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 4,8% Rialzo | Fai l’upgrade a Pro+ | |
Ansell | Sydney | Salute | Attrezzature e forniture medicali | 4,81 Mrd A$ | 35,9x | -0,83 | 33,30 A$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 1,4% Rialzo | Fai l’upgrade a Pro+ | |
Sigma Pharma | Sydney | Salute | Prodotti farmaceutici | 4,54 Mrd A$ | -1.440x | 12,85 | 2,90 A$ | -0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -30,4% Ribasso | Fai l’upgrade a Pro+ | |
Summerset Group | Sydney | Salute | Fornitori e servizi sanitari | 2,77 Mrd A$ | 7,4x | 0,15 | 11,71 A$ | -0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Regis Healthcare Ltd | Sydney | Salute | Fornitori e servizi sanitari | 2,05 Mrd A$ | -96,3x | -3,79 | 6,81 A$ | 3,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 6,1% Rialzo | Fai l’upgrade a Pro+ | |
Mesoblast | Sydney | Salute | Ricerca medica e biotecnologica | 2 Mrd A$ | -12,7x | -0,98 | 1,76 A$ | -4,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -23,5% Ribasso | Fai l’upgrade a Pro+ | |
Clarity Pharmaceuticals | Sydney | Salute | Ricerca medica e biotecnologica | 1,89 Mrd A$ | -44,3x | 0,77 | 5,79 A$ | -1,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 43,7% Rialzo | Fai l’upgrade a Pro+ | |
Neuren Pharma | Sydney | Salute | Prodotti farmaceutici | 1,64 Mrd A$ | 13,9x | 0,12 | 12,88 A$ | -3,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Polynovo | Sydney | Salute | Attrezzature e forniture medicali | 1,54 Mrd A$ | 278,1x | 1,41 | 2,22 A$ | -1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 27,5% Rialzo | Fai l’upgrade a Pro+ | |
Primary Health | Sydney | Salute | Fornitori e servizi sanitari | 1,02 Mrd A$ | -1,4x | 0,03 | 1,39 A$ | -1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -6,7% Ribasso | Fai l’upgrade a Pro+ | |
Nanosonics | Sydney | Salute | Attrezzature e forniture medicali | 982,91 Mln A$ | 74,9x | -2,16 | 3,25 A$ | -0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 7,3% Rialzo | Fai l’upgrade a Pro+ | |
Opthea | Sydney | Salute | Ricerca medica e biotecnologica | 886,39 Mln A$ | -1,3x | 0,37 | 0,72 A$ | -4,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 18,2% Rialzo | Fai l’upgrade a Pro+ | |
PYC Therapeutics Ltd | Sydney | Salute | Ricerca medica e biotecnologica | 795,57 Mln A$ | -17,7x | 0,65 | 1,69 A$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Paragon Care Ltd | Sydney | Salute | Attrezzature e forniture medicali | 782,96 Mln A$ | 52,2x | -2,88 | 0,47 A$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 11,6% Rialzo | Fai l’upgrade a Pro+ | |
Integral Diagnostics Ltd | Sydney | Salute | Fornitori e servizi sanitari | 722,80 Mln A$ | -11,9x | 0,03 | 3,04 A$ | 3,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 11,4% Rialzo | Fai l’upgrade a Pro+ | |
Australian Clinical Labs | Sydney | Salute | Fornitori e servizi sanitari | 705,47 Mln A$ | 28,2x | -0,88 | 3,63 A$ | 2,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 3,1% Rialzo | Fai l’upgrade a Pro+ | |
Clinuvel Pharmaceuticals Ltd | Sydney | Salute | Prodotti farmaceutici | 643,31 Mln A$ | 18x | 1,02 | 12,96 A$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Botanix Pharma | Sydney | Salute | Prodotti farmaceutici | 617,94 Mln A$ | -37,2x | 2,87 | 0,34 A$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Monash IVF Group Ltd | Sydney | Salute | Fornitori e servizi sanitari | 483,15 Mln A$ | -72,7x | 0,55 | 1,23 A$ | -0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 20,7% Rialzo | Fai l’upgrade a Pro+ | |
Oceania Healthcare | Sydney | Salute | Fornitori e servizi sanitari | 470,70 Mln A$ | -24,6x | 0,18 | 0,65 A$ | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Immutep | Sydney | Salute | Ricerca medica e biotecnologica | 458,19 Mln A$ | -8,9x | -0,54 | 0,32 A$ | -1,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |